규제 업데이트
2026년 9월 27일•1분 읽기
Teva Pharm's Ribavirin Oral Solution Receives Tentative FDA Approval (ANDA 077611)
The FDA granted a tentative approval for Teva Pharm's ribavirin oral solution (40 mg/mL) under ANDA 077611.
규제 업데이트
2026년 9월 25일•1분 읽기
Sandoz Secures Tentative FDA Approval for Generic Rosiglitazone Maleate Tablets (ANDA078674)
Sandoz's ANDA078674 for oral rosiglitazone maleate tablets (2 mg, 4 mg, 8 mg) has received tentative approval from the FDA as of March 9 2009.
규제 업데이트
2026년 9월 22일•1분 읽기
FDA Issues Tentative Approval for Atomoxetine Hydrochloride Capsules (ANDA078940)
The FDA has granted tentative approval for six oral capsule strengths of atomoxetine hydrochloride under ANDA078940, sponsored by Actavis Elizabeth.
규제 업데이트
2026년 9월 18일•1분 읽기
FDA Grants Tentative Approval for Dapagliflozin Tablets (ANDA219408)
Sciegen Pharmaceuticals received tentative FDA approval for 5 mg and 10 mg dapagliflozin tablets under ANDA219408.
2
규제 업데이트
2026년 9월 15일•1분 읽기
Sandoz Receives FDA Tentative Approval for Epinastine Hydrochloride Ophthalmic Solution (ANDA090950)
Sandoz's generic ophthalmic solution containing 0.05% epinastine hydrochloride has been granted tentative approval by the FDA under ANDA090950.
규제 업데이트
2026년 9월 15일•1분 읽기
FDA Tentative Approval for Reddys Escitalopram Oxalate Tablets
The FDA granted a Tentative Approval for Dr Reddys Labs' ANDA 077798, covering oral tablets of Escitalopram Oxalate in 5 mg, 10 mg, and 20 mg strengths.
규제 업데이트
2026년 9월 9일•1분 읽기
FDA Tentative Approval for Tolterodine Oral Tablets (ANDA 076953)
Ranbaxy received a tentative FDA approval for two oral tablet strengths of Tolterodine tartrate (1 mg and 2 mg) under ANDA 076953.
규제 업데이트
2026년 9월 3일•1분 읽기
Cipla’s ABACAVIR SULFATE Oral Solution Receives Tentative FDA Approval (ANDA 078348)
The FDA has granted a tentative approval for Cipla Limited’s ABACAVIR SULFATE oral solution (20 mg) under ANDA 078348.
규제 업데이트
2026년 9월 3일•1분 읽기
CARACO Receives Tentative FDA Approval for Escitalopram (ANDA078219)
CARACO's ANDA078219 for oral escitalopram oxalate tablets (5 mg, 10 mg, 20 mg) has been granted tentative approval by the FDA.
규제 업데이트
2026년 9월 3일•1분 읽기
Cipla Efavirenz 600mg Tablet Gets FDA Tentative Approval (ANDA 077916)
Cipla Limited’s generic efavirenz 600 mg tablet has been granted tentative approval by the FDA under ANDA 077916.
규제 업데이트
2026년 8월 24일•1분 읽기
Hikma Pharm's Rosiglitazone Maleate Tablet ANDA Receives Tentative Approval (ANDA078658)
FDA granted tentative approval to Hikma Pharm's ANDA078658 for three oral rosiglitazone maleate tablet strengths (2 mg, 4 mg, 8 mg).